Immuneering Corp. (IMRX)

4.94 -0.06 (-1.20%) USD  |  NASDAQ  |  Mar 03, 16:00
4.94 0.00 (0.00%) After-Hours: 20:00
More

Immuneering Stock Based Compensation (Annual Per Share)

Stock Based Compensation (Annual Per Share) Chart

View Stock Based Compensation (Annual Per Share) for IMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual Per Share) Range, Past 5 Years

View Stock Based Compensation (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual Per Share) Benchmarks

View Stock Based Compensation (Annual Per Share) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Verastem, Inc. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade